13 hours ago
Daily briefing: Why cancer might protect against Alzheimer’s disease
Neutral
Nature
Owner: Holtzbrinck Family
Jan. 23, 2026
Guinea-Bissau Suspends US-Funded Hepatitis B Vaccine Amid Ethical and Political Backlash
Neutral
Sri Lanka Guardian
Owner: Nilantha Ilangamuwa
Jan. 24, 2026
Top African Health Official Blasts Trump Administration’s Plans for Human Experimentation in Africa
Neutral
Futurism
Owner: Andrew Perlman & Matt Sechrest
Jan. 23, 2026
Guinea-Bissau suspends US-funded vaccine trial as African scientists question its motives
Neutral
Nature
Owner: Holtzbrinck Family
Jan. 22, 2026
Guinea-Bissau still debating controversial US hepatitis B vaccine trial
Neutral
Devex
Owner: Raj Kumar
Jan. 22, 2026
Guinea-Bissau says plans for controversial U.S.-funded vaccine study need further review
Neutral
STAT - Massachusetts
Owner: John Henry
Jan. 22, 2026
Guinea-Bissau suspends Trump-backed hepatitis B vaccine study for ethical review
Center-right
SRN News
Owner: Richard von Gnechten
Jan. 23, 2026
‘It’s the sovereignty of the country’: Guinea-Bissau says US vaccine study suspended
Center-left
The Guardian
Owner: The Scott Trust
Jan. 23, 2026
US-backed hepatitis B vaccine study halted in Guinea-Bissau
Neutral
Africanews
Owner: Pedro Vargas David & Luís Santos
Jan. 23, 2026
Today in Africa — January 22, 2026: Uganda’s Kizza Besigye’s Health Deteriorates in Detention, 35 Million Nigerians Face Hunger
Neutral
OkayAfrica
Owner: Isha Sesay
Jan. 22, 2026
Guinea Bissau US Hepatitis B Study
Indeterminate
The Barre-Montpelier Times Argus - Vermont
Owner: George “Scoop” Sample
Jan. 22, 2026
US-Funded Vaccine Trial in Africa on Hold: Health Minister
Right-wing
The Epoch Times
Owner: John Tang
Jan. 22, 2026
US-funded Guinea-Bissau Vaccine Study to Undergo Ethical Review, African Health Officials Say
Neutral
Medscape
Owner: Kohlberg Kravis Roberts (KKR & Co. Inc.)
Jan. 22, 2026
US-funded Guinea-Bissau vaccine study to undergo ethical review, Africa CDC official says
Center-right
SRN News
Owner: Richard von Gnechten
7 hours ago
Operation Harmattan’s Missing Piece: West Africa’s Synthetic Drug Rise
Indeterminate
Talking Drugs
Owner: Release Legal Emergency & Drugs Service Ltd
Jan. 20, 2026
Trump’s HHS Trashes Top African Health Organization as “Fake” and “Powerless”
Neutral
Futurism
Owner: Andrew Perlman & Matt Sechrest
Jan. 19, 2026
U.S.-funded hepatitis B vaccine study in Guinea-Bissau cancelled, Africa CDC says
Indeterminate
Peoples Gazette
Owner: Samuel Ogundipe
Jan. 19, 2026
Africa CDC confirms cancellation of US-funded hepatitis B vaccine study in Guinea-Bissau
Neutral
Premium Times
Owner: Dapo Olorunyomi
Jan. 16, 2026
Controversial CDC hep B vaccine study in Guinea-Bissau may be canceled
Neutral
CIDRAP
Owner: University of Minnesota
Jan. 16, 2026
Trump Administration Says It’s Not Canceling Tuskegee-Style Medical Study That Will Withhold Hepatitis Vaccine From Newborns
Neutral
Futurism
Owner: Andrew Perlman & Matt Sechrest